Skip to main content
. 2023 May 12;13:1164932. doi: 10.3389/fonc.2023.1164932

Figure 1.

Figure 1

PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flowchart for study selection of the RCTs related to hyperthermia intravesical chemo-therapy (HIVEC), bacillus Calmette–Guérin (BCG), mitomycin C (MMC), and transurethral resection of bladder tumor treatment (TURBt).